Dr Franz Brunnhuber MD, Consultant Clinical Neurophysiologist, King’s College Hospital

Born in Augsburg in the south of Germany, Medical school in Ulm, Board Certificate in Neurology in
Munich, Doctorate (Dr med) in Neurophysiology from University of Tübingen. Specialising in Epilepsy
at the Epilepsy Center in Kehl/Kork (Southwest Germany) before relocating to London following an
invitation by Prof C Binnie at King’s. First appointment in UK in Clinical Neurophysiology at Royal
London Hospital and King’s College Hospital in 2000. Then substantive appointment at King’s College
Hospital from 2003. Served as Clinical Lead in Neurophysiology from 2007 until 2013. His team won
an NHS innovation award in 2012 with the development of HVT. Organised several masterclasses on
video-telemetry and HVT in the UK and abroad. Next masterclass will be in Lausanne on the 11/10
2023. Involved in teaching and training of medical students, clinical physiologists and SpRs in
Neurophysiology, Neurology and Psychiatry.
Special interests, teaching and publications in: neuroprognostication in hypoxic brain injury,
presurgical evaluation in intractable epilepsy, EEG and suggestion in the diagnosis of dissociative
seizures, development of home monitoring service (HVT) and developing and providing cloud based
clinical Neurophysiological testing and monitoring to associate DHS in the region.

 Dr Franz Brunnhuber MD, King’s College Hospital
HVET is here to stay. It has become a mainstream service in the NHS and now comprises 80%
of the video telemetry service at King's College Hospital in London.
Firstly, we will provide a definition of HVET and a clarification of some terminological
ambiguities and uncertainties. We will also use the NHS vantage point as the starting point
for the HVET development.
HVET 1.0 or supervised HVET is the initial model of domestic recordings, which started in 2007
at King’s College Hospital. We discontinued this service model during the pandemic in 2020.
From 2019, an alternative model was in development.
In June 2020, we introduced this new model, a cloud-based HVET (HVET 2.0) into our clinical
VT service. Its potentials and advantages, which include resilience, scalability and flexibility,
will be reviewed in details. In addition, ‘HVT alternatives’ emerged inside and outside the NHS,
which require assessment and integration in the current services.
The concept of home HVT 3.0 is trying to address the question of an integrative multimodal
platform, which could allow not only more patient interaction and autonomy, but also the
integration of long term monitoring with HVT alternatives and an integration with electronic
patient records.
The presence of new services often from the private sector in and for the NHS, sometimes
from international providers raise the question of recording, reporting, archiving and training
standards. We hope that this discussion will find a home within the BSCN.